About half of all U.S. states now have policies that criminalize substance use during pregnancy, consider it grounds for civil commitment, or consider it child abuse or neglect. But research suggests that punitive policies aren't beneficial for infants or their mothers.
The National Health Service spends significantly less on pregnancy-related research compared with other health conditions. Funding for pregnancy research totaled £255 million from 2013 to 2017, or about £51 million a year. As pregnancy care costs the NHS £5.8 billion annually, this means that for every £1 spent on pregnancy care, less than 1 penny is spent on research.
This web-based tool aims to inform policymakers about the rates of neonatal abstinence syndrome by county across eight states from 2009 to 2015. This analysis is displayed via maps and interactive charts.
In small, rural towns like Bluefield, West Virginia, economies are hurting, the opioid epidemic is growing, and together they are taking a toll on a surprising population: pregnant women and their babies.
This study presents metrics to help work out what Tommy's should measure and how Tommy's should report impact. The aim is to work out how each contributes to Tommy's desired outcomes, namely the reduction of stillbirth, preterm birth and miscarriage.
By meeting the unmet health needs of incarcerated children, child health professionals can take the lead in addressing a major pediatric health issue while simultaneously addressing an under-discussed aspect of racial, ethnic, and socio-economic disparities.
RAND adjunct physician policy researcher Stephen W. Patrick gives testimony at a Senate Health, Education, Labor and Pensions Committee hearing on the impact of the opioid epidemic on children and families.
The nation's public umbilical cord blood banks provide benefits that far outweigh their costs and should continue to receive federal support, even though use of cord blood stem cells from the banks has been declining.
U.S. umbilical cord blood banks provide benefits that far outweigh their costs. The national cord blood system should continue to receive federal support, even though use of cord blood stem cells from the banks has been declining.
RAND studied trends affecting public cord blood banks and considered changes to the program to buttress banks' financial stability. Researchers found a system worthy of investment, especially if it helps improve the quality of the national inventory.